1. Home
  2. CWD vs JAGX Comparison

CWD vs JAGX Comparison

Compare CWD & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CWD
  • JAGX
  • Stock Information
  • Founded
  • CWD 2009
  • JAGX 2013
  • Country
  • CWD United States
  • JAGX United States
  • Employees
  • CWD N/A
  • JAGX N/A
  • Industry
  • CWD Real Estate
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CWD Finance
  • JAGX Health Care
  • Exchange
  • CWD Nasdaq
  • JAGX Nasdaq
  • Market Cap
  • CWD 4.5M
  • JAGX 3.9M
  • IPO Year
  • CWD 2023
  • JAGX N/A
  • Fundamental
  • Price
  • CWD $3.26
  • JAGX $2.03
  • Analyst Decision
  • CWD
  • JAGX Strong Buy
  • Analyst Count
  • CWD 0
  • JAGX 1
  • Target Price
  • CWD N/A
  • JAGX $60.00
  • AVG Volume (30 Days)
  • CWD 271.9K
  • JAGX 164.5K
  • Earning Date
  • CWD 11-13-2025
  • JAGX 11-12-2025
  • Dividend Yield
  • CWD N/A
  • JAGX N/A
  • EPS Growth
  • CWD N/A
  • JAGX N/A
  • EPS
  • CWD N/A
  • JAGX N/A
  • Revenue
  • CWD $32,323,000.00
  • JAGX $11,810,000.00
  • Revenue This Year
  • CWD N/A
  • JAGX $22.41
  • Revenue Next Year
  • CWD $56.47
  • JAGX $30.00
  • P/E Ratio
  • CWD N/A
  • JAGX N/A
  • Revenue Growth
  • CWD N/A
  • JAGX 15.96
  • 52 Week Low
  • CWD $1.63
  • JAGX $1.57
  • 52 Week High
  • CWD $48.00
  • JAGX $33.25
  • Technical
  • Relative Strength Index (RSI)
  • CWD 38.29
  • JAGX 48.16
  • Support Level
  • CWD $3.10
  • JAGX $1.77
  • Resistance Level
  • CWD $3.75
  • JAGX $2.21
  • Average True Range (ATR)
  • CWD 0.30
  • JAGX 0.19
  • MACD
  • CWD -0.11
  • JAGX -0.03
  • Stochastic Oscillator
  • CWD 11.19
  • JAGX 40.40

About CWD CaliberCos Inc.

CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: